Welcome to our dedicated page for First Horizon Corporation SEC filings (Ticker: FHN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to find the story behind First Horizon’s loan quality or capital ratios? Banking disclosures run hundreds of pages, and pinpointing credit risk details or tracking First Horizon insider trading Form 4 transactions can exhaust even seasoned analysts.
Our AI-powered platform turns that challenge into clarity. Need the First Horizon quarterly earnings report 10-Q filing without digging through exhibits? One click reveals key margin shifts and provisioning trends. Looking for First Horizon Form 4 insider transactions real-time? Get alerts the moment directors buy or sell. We host every form�10-K, 10-Q, 8-K, DEF 14A—so you’ll see First Horizon SEC filings explained simply, complete with red-flag highlights, sentiment scoring, and peer benchmarks.
Here’s how investors use these insights:
- First Horizon earnings report filing analysis that maps segment revenue to balance-sheet risk.
- Instant dashboards for understanding First Horizon SEC documents with AI—no accounting degree required.
- Alerts on First Horizon executive stock transactions Form 4 for governance and alignment checks.
- First Horizon annual report 10-K simplified to spotlight liquidity buffers, CECL methodology, and deposit mix.
- Deep dives into the First Horizon proxy statement executive compensation to see pay tied to performance.
- First Horizon 8-K material events explained so market-moving announcements are never missed.
With real-time EDGAR feeds, expert commentary, and concise AI summaries, you’ll turn dense disclosures into decisive action—saving hours while making better-informed calls on FHN.
First Horizon Corporation (FHN) � Form 144 filing. An unidentified insider has filed a notice to sell up to 38,010 common shares through Fidelity Brokerage Services on or after 22 Jul 2025. The proposed sale has an estimated market value of $843,864.62, based on recent prices disclosed in the form.
The shares originate from two employee stock-option grants exercised on 22 Jul 2025 (grants dated 11 Feb 2019 and 19 Feb 2020), representing 12,475 and 25,535 shares, respectively. No other sales by the filer were reported in the past three months. With 507.2 million shares outstanding, the planned disposition equals roughly 0.0075 % of total shares—an immaterial float supply increase in absolute terms.
The signer affirms no undisclosed adverse information and acknowledges potential criminal liability for misstatements. While the dollar amount is modest relative to FHN’s market capitalization, investors often monitor Form 144s as an indicator of insider sentiment and forthcoming supply.